A study of magnitude of diabetes and its management in chronic pancreatitis

Sethu Prabhu Shankar, Neelakandan Ramya, Wadgaonkar Udit Rajendra


Background: Chronic pancreatitis is a heterogeneous disease which leads to endocrine and exocrine dysfunction. Diabetes in chronic pancreatitis is important. Diabetes can develop by consequences of other diseases too.

Aim: To assess the magnitude of Diabetes in Chronic Pancreatitis subjects.

Materials and Methods: A cross sectional study was done among chronic pancreatitis subjects. The age group studied was between 25-60 years. The study period was 6 months. The sample size was based on case records. HbA1c levels were measured at 0th day (registration), 3rd month and 6th month. Data was collected with regard to alcohol consumption and smoking habits.

Results: The study group ranged between 25 to 60 years, 60 was males and 3 females. The HbA1C levels were measured and subjects classified. A total of 53 subjects were diabetic. 8 subjects were started on OHA and 45 subjects on insulin. The HbA1C levels were measured again at the end of 3rd month. The subject’s on OHA there was not much of reduction in HbA1C levels so they were stated on insulin. At the end of 6 months there was significant decrease in HbA1C levels when compared to OHA.

Conclusion: Our study suggests that diabetes is common in chronic pancreatitis. Diabetes in chronic Pancreatitis was more in smokers. This study also suggests insulin therapy is more effective than OHA in chronic pancreatitis

Keywords: Chronic pancreatitis (CP), Oral hypoglycaemic agents (OHA), Insulin.

Full Text:



American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2016;39(suppl 1):S13-22.

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S5-20.

Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28:338-42.

Zuidema PJ. Cirrhosis and disseminated calcification of the pancreas in patients with malnutrition. Trop Geogr Med. 1959;11:70-4.

GeeVarghese PJ, Pillai VK, Joseph MP, Pitchumoni CS. The diagnosis of pancreatogenous diabetes mellitus. J Assoc Physicians India. 1962;10:173-8.

Geevarghese PJ. Pancreatic diabetes. A clinicopathological study of growth onset diabetes with pancreatic calculi. Popular Prakashan, Bombay, 1968.

Balakrishnan V, Gopalakrishnan A. chronic pancreatitis. A prospective nationwide study of 1086 subjects from India. J Pancreas. 2008;9(5):593-600.

Cote GA, Yadav D, Slivka A. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2011;9:266-73.

Maisonneuve P, Lowenfels AB, Mullhaupt B. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut. 2005;54:510-4.

Facchini FS, Hollenbeck CB, Jeppesen J. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128-30.

Cryer PE, Haymond MW, Santiago JV, et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976;295:573-7.

Moran A, Brunzell C, Cohen RC. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care. 2010;33(12):2697-2708.

Johnston PC, Thompson J, Mckee A, Hamill C, Wallace I. Diabetes and Chronic Pancreatitis: Considerations in the Holistic Management of an Often Neglected Disease. J Diabetes Res. 2019:2487804. doi: 10.1155/2019/2487804